- Home
- EXEL vs HBANL Comparison
EXEL vs HBANL Comparison
Compare EXEL & HBANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- HBANL
- Stock Information
- Founded
- EXEL 1994
- HBANL N/A
- Country
- EXEL United States
- HBANL United States
- Employees
- EXEL N/A
- HBANL 19932
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- HBANL Major Banks
- Sector
- EXEL Health Care
- HBANL Finance
- Exchange
- EXEL Nasdaq
- HBANL Nasdaq
- Market Cap
- EXEL 9.8B
- HBANL N/A
- IPO Year
- EXEL 2000
- HBANL N/A
- Fundamental
- Price
- EXEL $36.34
- HBANL $25.40
- Analyst Decision
- EXEL Buy
- HBANL
- Analyst Count
- EXEL 18
- HBANL 0
- Target Price
- EXEL $37.59
- HBANL N/A
- AVG Volume (30 Days)
- EXEL 2.3M
- HBANL N/A
- Earning Date
- EXEL 05-13-2025
- HBANL N/A
- Dividend Yield
- EXEL N/A
- HBANL N/A
- EPS Growth
- EXEL 170.77
- HBANL N/A
- EPS
- EXEL 1.76
- HBANL N/A
- Revenue
- EXEL $2,168,701,000.00
- HBANL N/A
- Revenue This Year
- EXEL $5.78
- HBANL N/A
- Revenue Next Year
- EXEL $10.94
- HBANL N/A
- P/E Ratio
- EXEL $20.74
- HBANL N/A
- Revenue Growth
- EXEL 18.50
- HBANL N/A
- 52 Week Low
- EXEL $20.14
- HBANL N/A
- 52 Week High
- EXEL $40.26
- HBANL N/A
- Technical
- Relative Strength Index (RSI)
- EXEL 49.28
- HBANL 54.07
- Support Level
- EXEL $34.90
- HBANL $25.36
- Resistance Level
- EXEL $40.26
- HBANL $26.04
- Average True Range (ATR)
- EXEL 1.18
- HBANL 0.31
- MACD
- EXEL -0.13
- HBANL 0.06
- Stochastic Oscillator
- EXEL 40.67
- HBANL 56.76
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.